Featured Research

from universities, journals, and other organizations

Researchers Create Lung Cancer 'Cluster Bombs'

Date:
January 30, 2004
Source:
University Of Alberta
Summary:
The butcher, the baker, and the candlestick maker may be more famous, but the pharmacist, the engineer, and the doctor may be onto something big. The latter group has combined resources and knowledge to create a novel way to deliver a new lung cancer treatment. The new system, which uses "nanoparticle cluster bombs," has proven effective in treating cancerous lung cells in vitro.

The butcher, the baker, and the candlestick maker may be more famous, but the pharmacist, the engineer, and the doctor may be onto something big.

The latter group has combined resources and knowledge to create a novel way to deliver a new lung cancer treatment. The new system, which uses "nanoparticle cluster bombs," has proven effective in treating cancerous lung cells in vitro (in a petri dish), it was reported today in the International Journal of Pharmaceuticals. The research team from the University of Alberta will conduct in vivo tests (in live specimens) early this year, with plans for clinical trials to follow.

"Based on what we've been able to do so far, we have practical hopes that a new lung delivery platform for lung cancer can be established," said Dr. Raimar Loebenberg, a professor of pharmacy at the U of A.

The three researchers--Loebenberg; Dr. Warren Finlay, a U of A mechanical engineering professor; and Dr. Wilson Roa, a U of A oncology professor--have applied for a patent on the lung cancer nanoparticle drug delivery system.

Loebenberg explained that the drug sits in powder form in the inhaler, which is similar to the device that asthmatics use. However, the difference between regular drugs and "nanoparticle cluster bombs," Loebenberg said, comes when the powder arrives in the lungs, where it dissolves into nanoparticles upon contact with moisture in the lung--usually mucous.

Each grain of drug powder contains "a few thousand nanoparticles," Finlay explained. "Once the nanoparticles are active in the lung they have a tremendous advantage over regular drugs, because they are better able to do exactly what we want them to."

The idea is that the nanoparticles can be programmed to escape immune system surveillance like a Trojan Horse, and carry designer drugs that target cancer cells while leaving healthy cells alone.

"This drug and this delivery system have a lot of potential--there are a lot of different things we can do as we're able to control where and when the nanoparticles release their payload," said Finlay, who also has a patent pending on a new inhaler to go with the nanoparticle drug platform. "This platform system may be just the beginning. We're looking at a lot of cool things we can do down the road."

"At this point, we're excited and encouraged about what we've done and what we could do in the future," Loebenberg said, adding that the progress is due to the interdisciplinary collaboration between experts in three fields.

"This was not the result of one brain, but three," he said. "At first, when we started working together we didn't understand each other very well, but now I think we make a pretty good team, and I think we've created something that has good potential for a solution to lung cancer."


Story Source:

The above story is based on materials provided by University Of Alberta. Note: Materials may be edited for content and length.


Cite This Page:

University Of Alberta. "Researchers Create Lung Cancer 'Cluster Bombs'." ScienceDaily. ScienceDaily, 30 January 2004. <www.sciencedaily.com/releases/2004/01/040130074248.htm>.
University Of Alberta. (2004, January 30). Researchers Create Lung Cancer 'Cluster Bombs'. ScienceDaily. Retrieved July 31, 2014 from www.sciencedaily.com/releases/2004/01/040130074248.htm
University Of Alberta. "Researchers Create Lung Cancer 'Cluster Bombs'." ScienceDaily. www.sciencedaily.com/releases/2004/01/040130074248.htm (accessed July 31, 2014).

Share This




More Health & Medicine News

Thursday, July 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Xtreme Eating: Your Daily Caloric Intake All On One Plate

Xtreme Eating: Your Daily Caloric Intake All On One Plate

Newsy (July 30, 2014) The Center for Science in the Public Interest released its 2014 list of single meals with whopping calorie counts. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

    Environment News

    Technology News



      Save/Print:
      Share:

      Free Subscriptions


      Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

      Get Social & Mobile


      Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

      Have Feedback?


      Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
      Mobile: iPhone Android Web
      Follow: Facebook Twitter Google+
      Subscribe: RSS Feeds Email Newsletters
      Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins